H. pylori should be eradicated in chronic liver disease patients with peptic ulcer

Digestive and Liver Disease

Volumn 41, Issue 2, 2009, Pages 141-142

  Zullo, A ^a   Cristofari, F ^a   Hassan, C ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; DISACCHARIDE; DIURETIC AGENT; PROTON PUMP INHIBITOR;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; PEPTIC ULCER; PREVALENCE;

EID: 58149154508     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.11.004     Document Type: Note

References (6)

1. Vergara M., Calvet X., and Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 14 (2002) 717-722
2. Zullo A., Romiti A., Tomao S., Hassan C., Rinaldi V., Giustini M., et al. Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12 (2003) 179-182
3. Zullo A., Hassan C., and Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis 35 (2003) 197-205
4. Zullo A., Hassan C., and Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 37 (2003) 164-168
5. Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim YY, et al. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Dig Liver Dis, in press.
6. Huang J.Q., Zheng G.F., Hunt R.H., Wong W.M., Lam S.K., Karlberg J., et al. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World J Gastroenterol 11 (2005) 2726-2732